Neuroprotective effects of (-)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis. [electronic resource]
- Neurochemical research Oct 2006
- 1263-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0364-3190
10.1007/s11064-006-9166-z doi
Amyotrophic Lateral Sclerosis--drug therapy Animals Blotting, Western Caspase 3--metabolism Catechin--analogs & derivatives Disease Models, Animal Enzyme Activation Female Immunohistochemistry Male Mice Mice, Transgenic Microglia--pathology Motor Neurons--pathology NF-kappa B--metabolism Neuroprotective Agents--therapeutic use